« Home | Metabolon Wins Anthrax Vaccine Study Contract » | Letter to the Editor » | Emergent won't get anthrax vaccine contract » | BYRD, SANDERS SECURE FUNDS FOR GULF WAR ILLNESS RE... » | Military stockpiling unapproved vaccine - Canada » | IDF's medical experiments brought to court » | Petition: Stop medical experimentation on soldiers... » | Interview with Steve DeGuire - Biothrax Vaccine Ca... » | Government: Vaccines threaten up to 44,000 soldier... » | Anthrax Vaccine Side Effects Disable Many Military... »

Emergent (EBS) Provides Update on DoD Anthrax Vaccine, Cancels Request for Proposal


Emergent BioSolutions Inc. (NYSE: EBS) has been advised that the U.S. Department of Defense intends to pursue a collaborative arrangement with the U.S. Department of Health and Human Services to facilitate the use by DoD of stockpiled doses of BioThrax to prevent future waste of government funding and resources and that DoD is therefore cancelling its previously announced request for proposal.